C‐reactive protein during and after myocardial infarction in relation to cardiac injury and left ventricular function at follow‐up

Acute myocardial infarction (MI) invokes a large inflammatory response, which contributes to myocardial repair.

[1]  A. Mayr,et al.  Relation of inflammatory markers with myocardial and microvascular injury in patients with reperfused ST-elevation myocardial infarction , 2017, European heart journal. Acute cardiovascular care.

[2]  P. Libby,et al.  Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease , 2017, The New England journal of medicine.

[3]  F. Crea,et al.  Anti-inflammatory treatment of acute coronary syndromes: the need for precision medicine. , 2016, European heart journal.

[4]  S. Prabhu,et al.  The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. , 2016, Circulation research.

[5]  M. Nahrendorf,et al.  Innate immune cells in ischaemic heart disease: does myocardial infarction beget myocardial infarction? , 2016, European heart journal.

[6]  E. V. van Beek,et al.  Systemic Atherosclerotic Inflammation Following Acute Myocardial Infarction: Myocardial Infarction Begets Myocardial Infarction , 2014, Journal of the American Heart Association.

[7]  J. Denollet,et al.  Aerobic interval training and continuous training equally improve aerobic exercise capacity in patients with coronary artery disease: the SAINTEX-CAD study. , 2015, International journal of cardiology.

[8]  N. Frangogiannis,et al.  The inflammatory response in myocardial injury, repair, and remodelling , 2014, Nature Reviews Cardiology.

[9]  A. Hall,et al.  The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study , 2013, European heart journal.

[10]  Fred S Apple,et al.  Third universal definition of myocardial infarction , 2012 .

[11]  K. Dickstein,et al.  C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction. , 2009, European heart journal.

[12]  P. Libby,et al.  Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. , 2008, The New England journal of medicine.

[13]  L. Martínez-Dolz,et al.  Inflammatory markers in stable heart failure and their relationship with functional class. , 2008, International journal of cardiology.

[14]  G. Dagenais,et al.  Clinical utility of C-reactive protein measured at admission, hospital discharge, and 1 month later to predict outcome in patients with acute coronary disease. The RISCA (recurrence and inflammation in the acute coronary syndromes) study. , 2008, Journal of the American College of Cardiology.

[15]  A. Jaffe,et al.  Cardiac magnetic resonance imaging study for quantification of infarct size comparing directly serial versus single time-point measurements of cardiac troponin T. , 2008, Journal of the American College of Cardiology.

[16]  N. Lamblin,et al.  High-sensitivity C-reactive protein: potential adjunct for risk stratification in patients with stable congestive heart failure. , 2005, European heart journal.

[17]  M. Pfeffer,et al.  C-reactive protein levels and outcomes after statin therapy. , 2005, The New England journal of medicine.

[18]  Jing Ma,et al.  Inflammatory markers and the risk of coronary heart disease in men and women. , 2004, The New England journal of medicine.

[19]  Y. Ohnishi,et al.  Impact of high-sensitivity C-reactive protein on predicting long-term mortality of acute myocardial infarction. , 2003, The American journal of cardiology.

[20]  P. Ridker,et al.  C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. , 2000, The New England journal of medicine.

[21]  F. Van de Werf,et al.  Serum C-reactive protein and infarct size in myocardial infarct patients with a closed versus an open infarct-related coronary artery after thrombolytic therapy. , 1993, European heart journal.

[22]  H. Bøtker,et al.  Novel targets and future strategies for acute cardioprotection: Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart. , 2017, Cardiovascular research.